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Abstract
 
Elevated extracellular K
 
1
 
 ([K
 
1
 
]
 
o
 
), in the absence of “classical” immunological stimulatory sig-
 
nals, was found to itself be a sufficient stimulus to activate T cell 
 
b
 
1 integrin moieties, and to
induce integrin-mediated adhesion and migration. Gating of T cell voltage-gated K
 
1
 
 channels
(Kv1.3) appears to be the crucial “decision-making” step, through which various physiological
factors, including elevated [K
 
1
 
]
 
o 
 
levels, affect the T cell 
 
b
 
1 integrin function: opening of the
channel leads to function, whereas its blockage prevents it. In support of this notion, we found
that the proadhesive effects of the chemokine macrophage-inflammatory protein 1
 
b
 
, the neu-
ropeptide calcitonin gene–related peptide (CGRP), as well as elevated [K
 
1
 
]
 
o
 
 levels, are blocked
 
by specific Kv1.3 channel blockers, and that the unique physiological ability of substance
 
 
 
P to
inhibit T cell adhesion correlates with Kv1.3 inhibition. Interestingly, the Kv1.3 channels and
the 
 
b
 
1 integrins coimmunoprecipitate, suggesting that their physical association underlies their
functional cooperation on the T cell surface. This study shows that T cells can be activated and
driven to integrin function by a pathway that does not involve any of its specific receptors (i.e.,
by elevated [K
 
1
 
]
 
o
 
). In addition, our results suggest that undesired T cell integrin function in a
series of pathological conditions can be arrested by molecules that block the Kv1.3 channels.
Key words: T cells • extracellular K
 
1
 
 • potassium channels • integrins • 
neuroimmunomodulation
 
Introduction
 
It is generally accepted that T cells are physiologically acti-
vated to function upon stimulation by specific antigens, su-
perantigens, and immunocyte-secreted factors such as cy-
tokines and chemokines. These specific stimuli convey
their messages to the T cells through binding to specific
surface-expressed receptors, such as the TCR, and the re-
ceptors to cytokines, chemokines, and growth factors.
Here, we investigated whether the activation of human
resting T cells, resulting in rapid integrin-mediated func-
tions, can occur without any such “classical” immunologi-
cal triggering stimuli, and not necessarily through specific
receptors. Specifically, we questioned whether modifying
the ionic composition of the extracellular milieu, which
takes place under conditions of injury, stress, and even
normal neurotransmitter stimulation, and which is typi-
 
cally characterized by elevated levels of extracellular K
 
1
 
ions (1–10), can drive T cells into two integrin-mediated
T cell functions: adhesion to an extracellular matrix
 
(ECM)
 
1
 
 component, and migration.
These integrin-mediated T cell activities are carried out
only by activated T cells, and are required in a broad spec-
trum of normal and diseased conditions in general, and in
inflammation and injury in particular. The activation of
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the integrin moieties is a dynamic, rapid, and often tran-
sient process, and is the primary factor that allows T
cells to attach to their ligands on cell surfaces and matrices
(11, 12).
To date, the exact cellular mechanisms by which differ-
ent physiological stimuli activate integrins on lymphocyte
membranes have not been fully understood (13). More-
over, finding ways to selectively arrest integrin-mediated
adhesion and migration of T cells remains a major chal-
lenge in various pathophysiological conditions, such as
those involving T cell–mediated inflammation, graft rejec-
tion, autoimmunity, and malignancy.
In view of the above, we also investigated the possible
existence of a pivotal T cell membranal component that
operates as an on/off switch of 
 
b
 
1 integrin activation. We
postulated that depolarization that leads to the opening of
the T cell voltage-gated K
 
1
 
 channels may serve as a com-
mon merging step through which various integrin-activat-
ing molecules on one hand, and elevated extracellular K
 
1
 
([K
 
1
 
]
 
o
 
)
 
 
 
levels on the other, induce 
 
b
 
1 integrin function of
T cells.
 
Materials and Methods
 
T Cells.
 
Human T cells were purified from the peripheral
blood of healthy donors as follows: the leukocytes were isolated
on a Ficoll gradient, washed, and incubated on Petri dishes
(37
 
8
 
C, 10% CO
 
2
 
 humidified atmosphere). After 2 h, the nonad-
herent T cells were removed and incubated on nylon wool col-
umns (Novamed Ltd.). Nonadherent T cells were eluted,
washed, and passed through human CD3
 
1
 
 cell purification col-
umns (Cedarlane Laboratories Ltd.). The resulting cell popula-
tion was 
 
.
 
92% T cells, as evaluated by CD3 staining shown in
our previous studies. Myelin basic protein (amino acid sequence
87–99)–specific CD4
 
1
 
 T cell lines, of the Th2 phenotype, were
obtained from SJL/J mice as described (14). 
 
Membrane Potential Measurements by Flow Cytometry.
 
Purified
normal human T cells
 
 
 
were suspended (
 
z
 
3 
 
3 
 
10
 
6
 
/ml) in serum-
free medium for 1 h (37
 
8
 
C, 10% CO
 
2
 
) to assure steady-state con-
ditions. The cells were then distributed into individual tubes (
 
z
 
3 
 
3
 
10
 
6
 
/tube), washed, and resuspended either in normal RPMI or
in rich K
 
1
 
 RPMI solutions. After an additional 30-min incu-
bation (37
 
8
 
C, 10% CO
 
2
 
), 300 nM bis-(1,3-dibutylbarbituric
acid) trimethine oxonol (DiBAC
 
4
 
[3]) dye (Molecular Probes)
was added to the cells, and 5–10 min later the cells were applied
to the FACSort™ (Becton Dickinson); fluorescence was read at
488 nm.
 
Adhesion Assay.
 
Adhesion of purified normal human T cells,
isolated from a fresh human blood sample, was assayed in fi-
bronectin (FN)-coated microtiter flat-bottomed wells, as de-
scribed previously (15). In brief, normal human T cells, purified
from a fresh blood sample, were labeled with Na
 
2
 
[
 
51
 
Cr]O
 
4
 
,
washed, and resuspended in adhesion medium (RPMI 1640 sup-
plemented with 0.1% BSA, 1 mM Ca
 
2
 
1
 
, 1 mM Mg
 
2
 
1
 
, and 1%
Hepes buffer). The cells were then pretreated (30 min, 37
 
8
 
C)
with rich K
 
1
 
 solutions ranging from 10 to 50 mM K
 
1
 
, as indi-
cated in the specific experiment, or with the desired proadhesive
molecule, and added to FN-coated (1 
 
m
 
g/well; Sigma Chemical
Co.) microtiter flat-bottomed 96-well plates (10
 
5
 
 cells/well). The
plates were placed in a humidified incubator (37
 
8
 
C, 30 min, 10%
 
CO
 
2
 
), and then washed thoroughly several times with PBS to re-
move nonadherent T cells. The adherent T cells were lysed with
1% Tween 20 in 1 N NaOH, and the radioactivity in the result-
ing supernatants was determined in a 
 
g
 
-counter. For each exper-
imental group, results were expressed as the mean cpm 
 
6 
 
SD of
bound T cells from quadruplicate wells. Adhesion of treated T
cells to BSA-coated (rather than FN) wells, and adhesion of un-
treated T cells to FN-coated wells were the standard negative
controls.
 
Involvement of Specific Integrins in Elevated [K
 
1
 
]
 
o
 
-induced T Cell
Adhesion to FN.
 
51
 
Cr-labeled T cells were treated (30 min)
with mAbs (2 
 
m
 
g/ml) specific to human integrin moieties: the
CD29 molecule (the common 
 
b
 
1 integrin chain) or the 
 
a
 
2 and
 
a
 
5 chains of the very late antigen (VLA) integrins (Serotec). The
T cells were then suspended in rich K
 
1
 
 solutions and seeded in
FN-coated microtiter plates. The plates were returned to the in-
cubator for an additional 30-min incubation, and T cell adhesion
was determined as described previously.
 
Integrin-mediated Migration Assay.
 
Cell migration was mea-
sured as described previously (16) by using a modification of the
Boyden chamber assay. Cells were resuspended at 5 
 
3 
 
10
 
6
 
/ml ei-
ther in normal RPMI 1640 or in rich K
 
1
 
 RPMI solutions, both
supplemented with 1% BSA. The cells were then placed in the
upper wells of a 48-well chamber (50 
 
m
 
l/well). The lower well
of the migration chamber contained either normal RPMI (con-
trol) or a chemoattractant (macrophage-inflammatory protein
[MIP]-1
 
b
 
, 0.1 ng/ml). The upper and lower wells were sepa-
rated by a 8-
 
m
 
M-pore polycarbonate filter (Poretics), which was
precoated (2 h, 37
 
8
 
C in a 10% CO
 
2
 
 incubator) with bovine FN
(Sigma Chemical Co.) solution (0.1%). The chambers were in-
cubated at 37
 
8
 
C in a 10% CO
 
2
 
 incubator for 2 h.
The filters were fixed, stained with solutions from a Diff-Quik
staining kit (Dade Diagnostika GmbH), and mounted on slides
using histological methods. Cell migration was measured by
counting the number of cells migrating through the filter that
adhered to the lower part of the filter (facing the bottom cham-
ber). The cells that did not migrate remained either in the upper
chamber or adhered to the upper part of the filter, and were not
counted. Counting the migrating cells was performed using a
10
 
3
 
 microscope magnification in six replicate fields. The num-
bers represent the mean
 
 6 
 
SD of migrating cells per field.
 
Immunofluorescence Staining for Activated Integrins.
 
Freshly pu-
rified normal human T cells were incubated (18 h, 37
 
8
 
C, 7.5%
CO
 
2 
 
humidified atmosphere) in normal culture medium. The
cells were washed, counted, and 5 
 
3
 
 10
 
5
 
 cells were incubated in
elevated K
 
1
 
-RPMI medium (CO
 
2
 
 incubator, 30 min). When
needed, samples were preincubated with a Kv1.3 blocker for 20
min before being exposed to elevated K
 
1
 
 depolarizing medium.
The blockers remained in the cell suspension throughout the ex-
periment. The cells were then incubated with the HUTS 21
mAb (5 
 
m
 
l/sample; a gift from F. Sanchez-Madrid, Hospital de la
Princesa, Madrid, Spain), returned to the 37
 
8
 
C incubator for 10
min, and transferred to 4
 
8
 
C for 45 min. The cells were then
washed and resuspended in PBS, to which FITC-conjugated
goat anti–mouse antibody (1 
 
m
 
g/sample, 45 min, 4
 
8
 
C; Jackson
ImmunoResearch Laboratories) was added. After a final wash,
the cells were resuspended in cold staining buffer (PBS, 1% FCS,
0.01% sodium azide) and analyzed by FACSort™ (Becton Dick-
inson).
 
Electrophysiology.
 
Purified human T cells, plated on poly-
 
d
 
-lysine–coated glass coverslips, were placed in a 1-ml recording
chamber mounted on the stage of an Axiovert 35 inverted mi-
croscope (Carl Zeiss, Inc.). The whole-cell configuration of the1169 Levite et al.
patch-clamp technique (17) was used to record the potassium
macroscopic currents at room temperature (22 6 18C). Signals
were amplified using an Axopatch 200B patch-clamp amplifier
(Axon Instruments), filtered ,1 kHz through a 4-pole Bessel
low-pass filter. Data were sampled at 2.5 kHz and analyzed using
pClamp 6.0.2 software (Axon Instruments) and an IBM-compat-
ible 486 computer in conjunction with a DigiData 1200 interface
(Axon Instruments). The patch pipettes were pulled from boro-
silicate glass (fiber filled) with a resistance of 4–8 MV and were
filled (in mM) with 120 KCl, 2 MgCl2, 1 CaCl2, 11 EGTA, 10
Hepes, and 11 glucose at pH 7.4. The external solution con-
tained (in mM) 140 NaCl, 1 MgCl2, 2 CaCl2, 5 KCl, 11 glucose,
and 10 Hepes, at pH 7.4. All drugs used here were externally
perfused, and the whole-cell recordings were performed after the
effect reached saturation. Series resistances were in the range of 8
to 15 MV and were compensated by 90–95%. Before the peak
amplitude measurements, traces were leak-subtracted by the
Clampfit program (pClamp 6.0.2 software) and further analyzed
using Axograph 3.0 software (Axon Instruments). The I/V curve
was fitted by the Boltzmann distribution: I/Imax  5  a/{1  1
exp[(V50 2 VK)/s]}, where V50 is the half-maximal activation and
s is the slope of the curve. All of the data are expressed as mean
6 SEM.
Immunoprecipitation and Immunoblotting. Membrane fractions
were prepared as described (18) from fresh purified normal hu-
man T cells, incubated overnight with IL-2 (50 U/ml of human
recombinant IL-2; Chiron Corp.). Immunoprecipitation and im-
munoblotting were carried out as described (18). Polyclonal anti-
Kv1.3 was purchased from Alomone Labs. For immunoprecipita-
tion of the b1 integrins, we used a mouse anti–human CD29
(clone 3S3; Serotec), and for immunoblotting the b1 integrins we
used either the B44 (Chemicon) or the JB1B (Serotec) anti-CD29
antibodies, according to the manufacturer’s instructions. Control
anti–human IL-2 receptor antibody was purchased from Serotec.
Results
T Cells Are Depolarized by Elevated Levels of Extracellular
Potassium Ions. To test our hypothesis that T cells can be
activated and driven to integrin-mediated function by de-
polarization and the subsequent opening of voltage-gated
potassium channels, we first established conditions for pro-
ducing net depolarization, without any additional factors.
Thus, we prepared a series of RPMI solutions containing
increasing concentrations of K1 ions (on the expense of
decreasing concentrations of Na1 ions), exposed purified
normal human peripheral T lymphocytes to these solu-
tions, and measured the membrane potential by flow
cytometry using the voltage-sensitive oxonol dye,
DiBAC4(3). Fig. 1 A confirms the correlation between the
dye fluorescence intensity and the membrane potential (19,
20), and shows that human T cells are indeed depolarized
(right shift of the fluorescence curve) when exposed to so-
lutions containing elevated levels of K1 ions.
Figure 1. Elevated [K1]o levels depolarize hu-
man T cells and induce b1 integrin–mediated ad-
hesion to FN and motility. (A) Depolarization of
human T cells by elevated [K1]o levels. Human pe-
ripheral blood T cells were incubated in either nor-
mal RPMI, or in RPMI solutions containing ele-
vated concentrations (10–50 mM) of K1, and
supplemented with the voltage-sensitive oxonol
dye DiBAC4(3) (300 nM). The fluorescence inten-
sity (x-axis), proportional to the membrane poten-
tial (references 19, 20), was measured by FACS®.
(B) T cell adhesion to FN induced by elevated
[K1]o levels. Purified human T cells were labeled
with 51Cr, washed, and resuspended in either nor-
mal RPMI adhesion medium or in elevated [K1]o
RPMI solutions, and then added to FN-coated
wells. The results represent the mean cpm of four
to six independent adhesion microtiter wells. One
experiment representative of six is depicted. (C) T
cell adhesion induced by MIP-1b (20 ng/ml) or 25
mM [K1]o. (D) Elevated [K1]o increases the
chemotactic migration of resting human T cells to-
wards MIP-1b (0.1 ng/ml). The y-axis corresponds
to the number of cells that migrated to the lower
chamber and adhered to the bottom part of an FN-
coated filter separating the two chambers. The cells
were counted after fixation and staining. The re-
sults represent mean 6 SD of four replicates of one
of two experiments performed. (E) Purified human
T cells were pretreated with mAbs to the human
integrins CD29 (the common b1 chain), VLA-5
(a5), and VLA-2 (a2), and then exposed to an
RPMI solution containing 20 mM [K1]o. T cell
adhesion to FN was then determined. The results
represent the mean cpm 6 SD of four to six inde-
pendent adhesion microtiter wells. One experiment
representative of two.1170 Gating of K1 Channels Regulates T Cell Integrin Activation
Elevated Levels of Extracellular Potassium Ions Trigger Inte-
grin-mediated T Cell Adhesion and Migration. We  then
tested whether elevated [K1]o can trigger the adhesion of
T cells to FN, a major component of the ECM. The adhe-
sion of T cells to FN is known to be mediated by the b1
integrins, and to require their activation (15). Thus, we in-
cubated a similar number of Na2[51Cr]O4-labeled human T
cells in solutions containing increasing concentrations of
K1, and monitored their adhesion to FN-coated microtiter
well plates.
Fig. 1 B shows that exposure of the human T cells to el-
evated levels of [K1]o was sufficient to trigger their adhe-
sion to FN. The dose–response relationship shows that T
cell adhesion was induced by [K1]o . 15 mM, and that the
activation is an “all or none” phenomenon. Thus, once
reaching or exceeding the threshold, activation occurs, and
stronger depolarizations caused by higher [K1]o have no
further augmenting effect. These results suggest that it is
sufficient to depolarize the T cells to an extent that leads to
the opening of only a fraction of the voltage-gated chan-
nels in order to trigger integrin-mediated adhesion.
The levels of T cell adhesion induced by elevated [K1]o
were found to be comparable to those evoked by the po-
tent proadhesive and proinflammatory chemokines MIP-1b
(21; Fig. 1 C) and regulated upon activation, normal T cell
expressed and secreted (RANTES; data not shown).
We next investigated whether elevated levels of [K1]o,
in addition to causing T cells to adhere, could also aug-
ment their migration. We tested both migration towards
chemoattractants such as MIP-1b and IL-2 (16) and ran-
dom migration (motility). T cells were thus allowed to mi-
grate through a filter, from an upper chamber to a lower
chamber containing (or not) a chemoattractant. At the end
point, only the cells that migrated to the lower chamber
(16) were counted. Fig. 1 D shows that a much higher
number of T cells migrated towards MIP-1b after preincu-
bation (90 min) in an increased [K1]o (30 mM) medium
compared with normal (5 mM [K1]o) medium. Similar re-
sults were obtained when IL-2 was used as the chemoat-
tractant (data not shown). Interestingly, elevated [K1]o lev-
els substantially enhanced the migration of T cells, even
under conditions where no chemoattractant was present in
the lower chamber (data not shown), showing that the
overall random migration was increased. Together, these
results suggest that elevated [K1]o levels augment the basic
motility of T cells.
Elevated Levels of Extracellular Potassium Activate T Cell b1
Integrin Moieties. T cell recognition and adhesion to FN is
mediated primarily by the a4b1 and a4b1 integrins (13,
15, 22). To demonstrate that the adhesion to FN induced
by elevated [K1]o was mediated by these integrins, we used
mAbs specific for the b1 and a5 moieties, and a control
mAb directed against a nonrelevant a2 moiety of the
VLA-2 integrin. Fig. 1 E shows that adhesion to FN of
resting T cells induced by 25 mM [K1]o was specifically
and significantly inhibited by the presence of an mAb
against CD29 (the common b1 integrin chain), and by
the anti–VLA-5 mAb specific to the a5 integrin chain.
The adhesion was not influenced by the anti–VLA-2
(a2) mAb.
To obtain further direct evidence that elevated levels of
[K1]o activate the T cell b1 integrin moieties and thereby
promote T cell adhesion to ECM components, we used
the HUTS 21 mAb (23), which recognizes only the acti-
vated form of the b1 integrin, and is therefore termed an
“activation reporter” antibody, whereas the second is an
anti-CD29 mAb that inhibits the b1 integrin ligation. Fig.
2 A shows the immunofluorescence of T cells incubated ei-
ther in an elevated [K1]o medium or in normal medium,
and then stained with the HUTS 21 mAb followed by an
FITC-conjugated secondary anti–mouse antibody. The
clear shift in the fluorescence curve after T cell incubation
with high concentration of [K1]o compared with normal
[K1]o levels indicates that the b1 integrins were activated,
since only as such could they be recognized by the HUTS
21 mAb. Such activation was completely inhibited by a
specific Kv1.3 blocker, margatoxin (MgTx; at 0.1 mM), as
shown in Fig. 2 B. These results suggest that elevated levels
of [K1]o activate the T cell b1 integrin moieties and that
this activation is mediated by opening the voltage-gated K1
channels.
Taken together, these results confirmed that the T cell
adhesion to FN induced by elevated levels of [K1]o (like T
cell adhesion induced by chemokines, cytokines, neu-
ropeptides, and phorbol esters [15, 16, 21, 23]) is mediated
by the b1 integrins.
Various Physiological Molecules Trigger T Cell b1 Integrin
Function by Opening Voltage-gated K1 Channels. Can de-
polarization and the subsequent opening the voltage-gated
K1 channels be a common mechanism by which different
physiological stimuli (other than elevated levels of [K1]o)
activate the T cell b1 integrin–mediated functions? To an-
swer this question, we tested whether the proadhesive ef-
fects of the chemokine MIP-1b and the neuropeptide cal-
citonin gene–related peptide (CGRP [15]) are blocked by
various voltage-gated K1 channel blockers. Fig. 2 C shows
that three highly specific Kv1.3 blockers, MgTx, kaliotoxin
(KaTx), and noxioustoxin (NoTx), profoundly blocked
MIP-1b–induced T cell adhesion. Moreover, and in a
comparable manner, all three blockers fully inhibited
CGRP-induced T cell adhesion to FN (data not shown).
The concentrations at which these highly specific Kv1.3
channel blockers inhibited the integrin-mediated T cell ad-
hesion fall well within the concentration range (1–100 nM)
previously reported to be effective for blockage of other T
cell functions (19, 24–26).
To further support the involvement of the Kv1.3 chan-
nel in the b1 integrin–mediated T cell function, and to in-
vestigate the possible contribution of other ion channels,
we tested a series of additional channel blockers regarding
their effect on MIP-1b and CGRP-driven T cell adhesion
to FN. The relevant blockers included charybdotoxin
(ChTX) and tetraethylammonium (TEA), which block
both voltage-gated and large conductance Ca21-dependent
K1 channels, and 4-aminopyridine (4-AP) and quinine,
which block only voltage-gated K1 channels. The nonrele-1171 Levite et al.
vant blockers (controls) included: apamin, a small conduc-
tance Ca21-dependent K1 channel blocker; dendrotoxin, a
blocker of the Kv1.1 and Kv1.2 voltage-gated K1 channels,
which are not expressed in human T lymphocytes; picro-
toxin, a Cl2 channel blocker; tetrodotoxin (TTX), an Na1
channel blocker; and 6-cyano-7-nitroquinoxaline-2,3-
dione (CNQX), a glutamate/a-amino-3-hydroxy-5-methyl-
4-isoxazolepropionic acid (AMPA)-gated receptor channel
blocker. 
The results showed that T cell adhesion induced by
MIP-1b (Fig. 2 D) and by CGRP (Fig. 2 E) is specifically
blocked by the four voltage-gated K1-channel blockers
ChTX, TEA, 4-AP, and quinine and unaffected by all
other nonrelevant blockers.
When the results of the usage of the above 13 different
blockers are taken together, and considering the similar
pharmacological profiles and order of potency of the Kv1.3
blockers, it appears that the mechanism by which MIP-1b
and CGRP induce T cell adhesion involves the opening of
the voltage-dependent Kv1.3 channel.
Is the T cell adhesion induced by elevated levels of
[K1]o, such as that induced by MIP-1b and CGRP, also
mediated by the Kv1.3 channel? If so, it should be blocked
by the specific Kv1.3 blockers. Fig. 3, A–C, shows that 25
mM [K1]o–induced T cell adhesion was inhibited, in a
dose-dependent manner, by the three highly specific Kv1.3
blockers MgTx (A), KaTx (B), and NoTx (C). Complete
inhibition was exerted also by ChTX, TEA, 4-AP, and
quinine, whereas the other nonrelevant blockers had no ef-
fect (Fig. 3 D). Once again, the concentrations of the
blockers found effective to block the elevated [K1]o-
induced integrin-mediated T cell adhesion are in line with
those used to block other T cell activities and functions
(19, 24–26). These findings show that T cell adhesion in-
duced by elevated levels of [K1]o  (as by MIP-1b and
CGRP) requires the opening of voltage-gated Kv1.3 chan-
nels.
The Unique Physiological Ability of Substance P to Block T
Cell Adhesion Correlates with an Inhibitory Effect on Voltage-
gated K1 Currents. Can the T cell Kv1.3 channels be
blocked by physiologically relevant molecules, rather than
by toxins? This question arises because, although numerous
factors promote integrin-mediated T cell adhesion to FN,
to the best of our knowledge no physiological compounds
known to block this function have so far been identified.
However, in a previous study (15), we found that substance
P (Sub P), through its T cell–expressed NK1 receptor, and
at physiological concentrations, has a so far unique ability
to block integrin-mediated adhesion of T cells to FN, in-
duced by a variety of proadhesive factors. Accordingly, we
tested whether Sub P can also inhibit T cell adhesion in-
duced by elevated levels of [K1]o. Fig. 3, E and F, shows
that Sub P completely blocks T cell adhesion induced by
either CGRP or elevated levels of [K1]o. The dose–response
curve for this inhibition resembles that observed for the in-
hibition by Sub P of other proadhesive molecules, includ-
ing MIP-1b (15).
Can the inhibitory effect of Sub P on T cell adhesion be
explained, at least in part, by the blocking of Kv1.3 chan-
nels? To answer this question, we tested, by electrophysio-
Figure 2. (A) Elevated [K1]o levels acti-
vate b1 integrin moieties. Human T cells
were incubated either with a normal 5 mM
RPMI solution (gray line, filled histograms)
or with RPMI solutions containing ele-
vated levels of K1 (black line, open histo-
grams) and stained with the anti-activated
b1 integrin (HUTS 21) mAb. (B) Human
T cells were treated as in A, but in the pres-
ence of MgTx (1027 M). (C) Inhibition of
MIP-1b–induced T cell adhesion by
Kv1.3-specific blockers MgTX, KaTX, and
NoTX. (D and E) Inhibition of MIP-1b
and CGRP-induced T cell adhesion by ad-
ditional relevant and nonrelevant ion chan-
nel blockers ChTX (1028 M), TEA (1023
M), 4-AP (1024 M), quinine (Quin, 1025
M), picrotoxin (PicTx, 1025 M), TTX
(1026 M), CNQX (1027 M), apamin
(Apam, 5 3 1029 M), and dendrotoxin
(DnTx, 1027 M). The results represent the
mean cpm 6 SD of four to six independent
adhesion microtiter wells.1172 Gating of K1 Channels Regulates T Cell Integrin Activation
Figure 3. Elevated [K1]o-
induced T cell adhesion is blocked
by Kv1.3 channel blockers and
Sub P, and unaffected by non-
relevant blockers. 51Cr-labeled
human T cells were incubated in
elevated [K1]o RPMI solutions
and added with 1029 to 1027 M
MgTx (A), KaTx (B), or NoTx
(C), or with an additional series
of relevant and nonrelevant ion
channel blockers (D; as speci-
fied in the legend to Fig. 2, D
and E). The adhesion of the T
cells to FN-coated wells was
then measured. Similarly, hu-
man T cells were exposed either
to CGRP (1028 M; E) or to an
elevated (25 mM) [K1]o-con-
taining solution (F), in the pres-
ence or absence of Sub P (1028
M), and then tested for their ad-
hesion to FN. BG, background
adhesion. Each figure represents
one of three experiments per-
formed; data are expressed as the
mean 6 SD of four replicate mi-
crotiter wells.
Figure 4. (A) Electrophysiologi-
cal recordings of whole-cell K1 cur-
rents from purified human T cells,
in the presence of Sub P (10 nM)
and various Kv1.3 channel block-
ers. Typical whole-cell K1 currents
were obtained by stepping the
membrane from a holding potential
of 280 mV to 160 mV (500 ms) in
10-mV increments. The effect satu-
rated after z8 min. Quinidine (10
mM) and ChTX (10 nM) inhibited
the maximal amplitude of the K1
currents by 90 and 46%, respec-
tively. Apamin, as a negative con-
trol, had no inhibitory effect on the
K1 currents. The peak amplitudes of
the control (u, n 5 13), apamin (5 nM; j, n 5 8), ChTX (10 nM; s, n 5 11), Sub P (10 nM; d, n 5 10), MgTx (10 nM; n, n 5 5), and quinidine
(10 mM; m, n 5 9) were plotted against the voltage step and fitted using the Boltzmann distribution. Statistical difference is expressed by SE. (B) Physi-
cal association between Kv1.3 channels and b1 integrins in human T cells. Top, The extract of membrane fraction prepared from purified normal hu-
man T cells was subjected to parallel immunoprecipitations (IP) with either anti–b1 integrin (CD29), anti-Kv1.3, or preimmune (P.I.) negative control
antibodies. Immunoblotting of these precipitated immune complexes, as well as of a portion of the lysate (Input, 10%), was carried out using an anti–b1
integrin antibody. The b1 integrin is detected in membrane extracts precipitated with either the anti–b1 integrin or the anti-Kv1.3 antibody, as well as
in the lysate. Bottom, Similar immunoprecipitation as in the top panel, and blotting with the anti-Kv1.3 antibody. The Kv1.3 protein is detected in
membrane extracts precipitated with either the anti-Kv1.3 or the anti–b1 integrin antibody. Two different gels from two independent experiments are
shown to illustrate the immunoprecipitation of Kv1.3 either by anti-Kv1.3 antibodies (left) or by anti-CD29 antibodies (right).
logical techniques, whether Sub P, in a similar manner to
its primary action on neurons (27), reduces the T cell
membrane voltage-dependent [K1] conductance. Whole-
cell membrane currents were recorded from normal human
T cells, in the presence of Sub P, using the voltage-clamp
technique (17). Known blockers (MgTx, NoTx, ChTX,
quinidine, and apamin) served as positive and negative con-
trols. These experiments were performed while keeping in
mind that one cannot expect a parallel potency relationship
between the block of T cell adhesion and the block of1173 Levite et al.
Kv1.3 channels measured in an electrophysiological setting,
since the two experimental systems differ in almost every
single parameter (e.g., composition of the extracellular me-
dium, T cell condition [i.e., whether or not the T cell is in-
tact or in suspension], temperature, incubation time, and
the number of cells examined at a time).
Representative whole-cell currents are shown in Fig. 4
A. The membrane of untreated human T cells was stepped
from a holding potential of 280 mV to 160 mV, in 10-
mV increments. After application of Sub P (10 nM), the
maximal K1 currents were reduced by 39%, from 241 6
14 pA (n 5 10) to 148 6 24 pA (n 5 10). A 100-fold
higher Sub P concentration (1 mM) reduced the current by
z45%, to 109 6 11 pA (n 5 10).
The amplitude measurements were performed at the
peak of the currents, in response to 160 mV. Application
of MgTx (10 nM) and quinidine (10 mM) inhibited almost
completely (90%) the K1 currents (Fig. 4 A), from 204 pA 6
14.3 (n 5 13) to 21.3 6 3.5 (n 5 9), whereas ChTX (10
nM) inhibited the K1 currents by 46%, from 204 pA 6
14.4 (n 5 13) to 109.3 6 7.5 (n 5 11). In agreement with
the T cell adhesion experiments, the application of apamin
(5 nM) had no effect on the T cell K1 currents (202.8 6
25.7, n 5 8, vs. 204 6 14.3 pA).
These results demonstrate that Sub P blocks the voltage-
gated K1 currents in T cells (like known Kv1.3 blockers),
and suggest that its inhibitory effect on T cell adhesion is
mediated, at least partially, by Kv1.3 channel blocking.
These results also suggest that it is sufficient to close only a
fraction of the Kv1.3 channels in order to block the T cells
b1 integrin function.
Naturally, Sub P may affect the integrins and the adhe-
sion process by multiple mechanisms, including K1 chan-
nel–dependent and K1 channel–independent pathways.
Nevertheless, in view of the recent suggestion that the
Kv1.3 channel may be an attractive target for immune sup-
pression (19), Sub P can now be considered as a relevant
physiological effector.
A Physical Association between the T Cell Voltage-gated
Kv1.3 Channels and b1 Integrins. Regarding the mecha-
nism by which the T cell voltage-gated K1 channels “talk”
to the b1 integrins and consequently affect their activation
state, we investigated whether there is a physical association
among these membranal components. Such an association
may allow direct communication between these two enti-
ties. Accordingly, we prepared membranes from purified
normal human T cells and performed parallel immunopre-
cipitations with the anti–b1 integrin mAb and the anti-
Kv1.3 antibody. As controls, the T cell membrane extracts
were immunoprecipitated with an irrelevant anti–IL-2 re-
ceptor antibody, and with IgG from nonimmunized (pre-
immune) animals. Immunoblotting of these different im-
munoprecipitations with the anti-CD29 antibody (Fig. 4
B, top) showed the presence of the b1 integrin in the
membrane extracts immunoprecipitated with either the
anti-CD29 or the anti-Kv1.3 antibody, but not in mem-
brane extracts precipitated with the anti–IL-2 receptor an-
tibody (data not shown) or with the control IgG from non-
immunized mice. The immunoblots showed an apparent
molecular weight of z130 kD for the b1 integrin. This is
consistent with previous studies (28, 29) showing that the
apparent molecular weight of the b1 subunit ranges from
115 to 140 kD, depending on the maturity of the proteins,
i.e., mainly on posttranslational modifications such as gly-
cosylation.
Reciprocally, when the same immunoprecipitation
products were blotted with the anti-Kv1.3 channel anti-
body, the Kv1.3 protein (mol. wt. 60 kD) was recognized
in membranes immunoprecipitated with either the anti-
Kv1.3 or the anti-CD29 antibody, but not in those precip-
itated with the control antibodies (Fig. 4 B, bottom).
Taken together, these results show that the anti–b1 inte-
grin antibody precipitated the Kv1.3 protein (as well as the
b1 integrin itself), and that the anti-Kv1.3 antibody precip-
itated the b1 integrin protein (as well as the Kv1.3 protein).
The results suggest that the Kv1.3 channels and the b1 in-
tegrins are physically associated in normal human T cells,
and may therefore have the potential to communicate di-
rectly with one another.
Discussion
Extracellular elevated K1 ion concentrations were re-
ported in various pathophysiological situations, such as in-
jury to the central and peripheral nervous systems, trauma,
tissue ischemia (cerebral and myocardial), epilepsy, local in-
flammation, and metabolic poisoning (1–8), as well as after
neurotransmitter stimulation (9, 10). Neurons, like many
other cell types, can be depolarized by elevated levels of
[K1]o.
Interestingly, a recent study (9) showed an elevation of
the extracellular K1 level (of up to 16 mM above the nor-
mal [K1]o) in the myoendothelial space, effluxing from en-
dothelial cells in response to stimulation by acetylcholine
and muscarinic agonists. This endothelium-derived ele-
vated [K1]o was shown to shift the membrane potential of
adjacent smooth muscle cells, and to rapidly relax the arter-
ies. These observations indicate that fluctuations in [K1]o
levels, originating within the blood vessel itself, are impor-
tant in regulating mammalian blood pressure and flow.
Can such a simple modification of the ionic extracellular
environment also be a trigger for T cell function? Taken
together, the results presented here demonstrate that an el-
evated [K1]o level is indeed a sufficient trigger for activa-
tion of T cell b1 integrin moieties, and thereby for activa-
tion of integrin-mediated functions. Thus, we propose that
such a mechanism, not realized thus far, does exist,
whereby a mere excess of extracellular K1 ions in the envi-
ronment of a modified tissue initiates T cell integrin-medi-
ated immune reactions. The latter reactions are absolutely
essential for extravasation and the subsequent migration of
T cells from the blood vessels into tissues, and for various
other immune reactivities (22).
Our proposed scheme (Fig. 5), illustrating our findings
and current thoughts and incorporating several relevant
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of [K1]o may occur in at least two immunologically rele-
vant situations: (a) upon injury, elevated [K1]o levels may
result from a nonspecific efflux through a leaky membrane
of injured, damaged, metabolically impaired, or stressed
cells (other than T lymphocytes); and (b) under normal or
inflamed conditions, local nerve endings may release neu-
rotransmitters that may cause a channel-mediated efflux of
K1 ions from different non-T target cells. Recently re-
ported examples are the effect of acetylcholine on endo-
thelial cells (9) and the effect of N-methyl-d-aspartate
(NMDA) on neurons (10).
We propose that the elevated [K1]o from these two glo-
bal sources may depolarize neighboring or patrolling T
cells, leading to Kv1.3 gate opening and integrin activation.
In parallel, neurotransmitters may directly stimulate T
cells through their respective receptors (shown here for
CGRP and in our recent studies [14, 15] also for soma-
tostatin and neuropeptide Y). Such stimulation may have
the ability to depolarize the T cells, and may follow a simi-
lar integrin-activation path. In addition, neurotransmitters
can directly induce other T cell functions, such as cytokine
secretion, as shown previously in our recent study (14).
Hence, the combined activity of locally secreted neu-
rotransmitters may represent the rapid beneficial contribu-
tion of the nervous system to the undergoing function of
the immune system in a troubled locus.
The mechanism by which the elevated [K1]o level trig-
gers b1 integrin–mediated T cell activity involves depolar-
Figure 5. A speculated scheme
for the activation of T cell b1 in-
tegrin function by elevated extra-
cellular K1, and the crucial role of
the Kv1.3 channels. See Discus-
sion for details.1175 Levite et al.
ization and the subsequent opening of Kv1.3 voltage-gated
K1 channels, which are suggested in this study to be physi-
cally associated with the b1 integrins. Based on our results,
we hypothesize that this phenomenon reflects a “tyranny of
the minority,” whereby it is sufficient to open only a frac-
tion of the Kv1.3 channels in order to activate the T cell
b1 integrin function, or to close only a fraction of the
channels in order to block it. We further speculate that the
opening of the Kv1.3 channels after depolarization is asso-
ciated with a conformational change of the channel, which
in turn imposes a conformational change of the neighbor-
ing b1 integrin moieties, leading to their activation. This,
taken together with previous observations showing that T
cell depolarization caused by voltage-gated K1 channels
blockers does not allow activation of the cells (24), suggests
that the above Kv1.3 conformational change and/or efflux
of K1 ions through the newly opened channels, rather than
the modulation of the membrane potential per se, may be
the major factor contributing to the activation of the sur-
face-expressed integrins and to the subsequent integrin-
mediated function.
Although our study provides the first evidence of a phys-
ical and functional interaction between voltage-gated K1
channels and b1 integrin moieties in T lymphocytes, a
functional interaction between integrins and the G pro-
tein–activated inward rectifier K1 (GIRK) channels was re-
cently observed in the heart and brain (30). The GIRK
channels, through their conserved amino acid sequence
Arg-Gly-Asp (RGD) sequences (absent in Kv1.3 channels),
may directly bind to integrins. Moreover, integrins have
been previously shown to be linked to the activity of K1
channels (other than Kv1.3) in other cell types (31–34).
In T cells, the voltage-gated K1 channels (35, 36) are re-
sponsible for setting the membrane potential and for regu-
lating the cellular volume after exposure to hypoosmotic
solutions (37). The expression of the Kv1.3 (also termed n
type) channel in murine T cells varies consistently with the
cellular developmental state and functional class (37, 38).
Numerous studies have shown that K1 channel blockers
can inhibit T cell function, concluding that the voltage-
gated K1 channels are required for T lymphocyte activa-
tion (19, 24, 25, 35–37, 39). The results of the present
study demonstrate that the Kv1.3 channel plays a critical
role in a sequence of events that leads from external stimuli
(such as specific chemokines and neurotransmitters on the
one hand, and elevated [K1]o on the other) to the activa-
tion and function of the T cell b1 integrins.
In addition, this study identifies novel physiological mod-
ulators of the Kv1.3 channels, and thus of integrin-mediated
T cell activity: the neuropeptide CGRP, the chemokine
MIP-1b, and elevated extracellular K1 levels as activators,
and in contrast, the neuropeptide Sub P as a blocker.
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